Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

American Journal of Human Genetics

Volumn 63, Issue 5, 1998, Pages 1341-1351

  Tonin, Patricia N ^a   Mes Masson, Anne Marie ^b,c   Futreal, P Andrew ^g   Morgan, Kenneth ^a   Mahon, Jmichelle ^b,c   Foulkes, William D ^a,f   Cole, David E C ^h   Provencher, Diane ^b,c   Ghadirian, Parviz ^d,e   Narod, Steven A ⁱ  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b Institut du Cancer de Montreal   (Canada)

^c Dept de Médecine ^*

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e U de Rech an Epidemiol

^f MCGILL UNIVERSITY   (Canada)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY HEALTH NETWORK   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATION RATE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

FALLOPIA;

EID: 0032231382     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302099     Document Type: Article

References (56)

1. Berman DB, Costals J, Schultz DC, Grana G, Daly M, Godwin F AK (19960) A common mutation in BRCA2 that predisposes ; to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 56:3409-3414
2. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Goodwin AK (1996b) Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG mutation kindreds. Am J Hum Genet 58:1166-1176
3. Bouchard G, Laberge C, Scriver CR (1988) Reproduction démographique et transmission génétique dans le nord-est de la province de Québec (18e-20e siècles). Eur J Popul 4:39-67
4. Brais B, Xie Y-G, Sanson M, Morgan K, Weissenbach J, Korczyn AD, Blumen SC, et al (1995) The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac α and β myosin heavy chain genes on chromosome 14q11.2-q13. Hum Mol Genet 4:429-434
5. Casaubon LK, Melanson M, Lopes-Cendes I, Marineau C, Andermann E, Andermann F, Weissenbach J, et al (1996) The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q. Am J Hum Genet 58:28-34
6. Charbonneau H, Desjardins B, Guillemette A, Landry Y, Légaré J, Nault F ( 1987) Naissance d'une population: les Français établis au Canada au XVIIe siècle. Presse de l'Université de Montréal, Montreal
7. Charbonneau H, Robert N (1987) The French origins of the Canadian population 1608-1759. In: Harris RC (ed) From the beginning to 1800. Vol 1 in: Historical atlas of Canada. University of Toronto Press, Toronto, plate 45
8. Couch FJ, Rommens JM, Neuhausen SL, Bélanger C, Dumont M, Abel K, Russell B, et al (1996) Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics 36:86-99
9. Davignon J, Roy M (1993) Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect. Am J Cardiol 72:6D-10D
10. De Braekeleer M, Dao TN (1993) Founder effect in beta-thalassaemia in Portneuf, Quebec. Nouv Rev Fr Hematol 35:447-450
11. _ (1994a) Hereditary disorders in the French Canadian population of Quebec. I. In search of founders. Hum Biol 66:205-223
12. _ (1994b) Hereditary disorders in the French Canadian population of Quebec. II. Contributions of Perche. Hum Biol 66:225-249
13. Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA, Simard J (1996) Mutation analysis of BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet 33:814-819
14. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, et al (1996) Germline BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334:143-149
15. Friedman L, Ostermeyer E, Szabo C, Dowd P, Butler L, Park T, Lee MK, et al (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284-1297
16. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF9 Ponder BAJ (1997) Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60:1239-1242
17. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for phenotype-genotype correlations. Nat Genet 11:428-433
18. Hakansson S, Johannsson O, Johansson U, Selberg G, Loman N, Gerdes A-M, Holmberg E, et al (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandanavian familial breast cancer. Am J Hum Genet 60:1068-1078
19. Heyer E, Trembley M (1995) Variability of the genetic contribution of Quebec population founders to some deleterious genes. Am J Hum Genet 56:970-978
20. Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, et al (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10:208-212
21. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Eikiksdottir G, Johannsson OT, Borg A, et al (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663-3665
22. Johannsson O, Ostermeyer EA, Hakannson S, Friedman LS, Johansson U, Sellberg G, Brondum-Nielsen K, et al (1996) Founding BRCA1 mutations in hereditary breast and ovar- ian cancer in southern Sweden. Am J Hum Genet 58:441-450
23. Labuda D, Zietkiewicz E, Labuda M (1997) The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim. Am J Hum Genet 61:768-771
24. Labuda M, Labuda D, Korablaskoska M, Cole DEC, Zeitkeiwicz E, Weissenbach J, Popowska E, et al (1996) Vitamin D deficiency, rickets, and the founder effect in French Canadians. Am J Hum Genet 59:633-643
25. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059-1067
26. Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gaytherson SA, et al (1996) A polymorphic stop codon in BRCA2. Nat Genet 14:253-254
27. Miki Y, Swenson J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigan S, Lui Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
28. Morin C, Mitchell G, Larochelle J, Lambert M, Ogier H, Robinson BH, De Braekeleer M (1993) Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet 53:488-96
29. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ, et al (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254-264
30. Neuhausen S, Gilweski T, Norton L, Tran T, McGuire P, Swensen J, Hempel H, et al (19960) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128
31. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, et al (1996b) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271-280
32. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190
33. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW, Hogervost F, et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041-1049
34. Phelan C, Lancaster J, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, et al (1996) Mutation analysis of 49 site-specific breast cancer families. Nat Genet 13:120-122
35. Podratz KC, Podczaski ES, Gaffey TA, O'Brien PC, Schray MF, Malkasian GD Jr (1986) Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 154:1319-1326
36. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gathyer SM, Csokay B, Ponder BAJ, et al (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60:1242-1246
37. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
38. Rozen R, De Braekeleer M, Daigneault J, Ferreira-Rajabi L, Gerdes M, Lamoureux L, Aubin G, et al (1992) Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am J Med Genet 42:360-364
39. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, et al (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 and BRCA2. Am J Hum Genet 60:1031-1040
40. Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, et al (1996) A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:42-51
41. Serova-Sinilnikova OM, Boutrand L, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Dubois V, Lasset C, Janin N, et al (1997) BRCA2 mutations in hereditary breast and ovarian cancer in France. Am J Hum Genet 60:1236-1239
42. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, et al (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 273:535-541
43. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA 278:1242-1250
44. Simard J, Tonin P, Durocher F, Morgan K, RommensJ, Gingras S, Samson C, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet 8:392-398
45. Stajich JM, Gilchrist JM, Lennon F, Lee A, Yamaoka L, Helms B, Gaskell PC, et al (1996) Confirmation of linkage of oculopharyngeal muscular dystrophy to chromosome 14q11.2-q13. Ann Neurol 40:801-804
46. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60:1021-1030
47. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, et al (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-1130
48. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995a) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent inAshkenazi Jewish individuals. Nat Genet 11:198-200
49. J Struewing JP, Brody LC, Erdos MR, Kae RG, Giambarresi TR, Smith SA, Collins FS, et al (1995t) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Gener 57:1-7
50. Szabo CI, King M-C (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
51. Tavitgian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, et al (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337
52. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, et al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189
53. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179-1183
54. Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhonen S, Ponder BAJ, Muhonen T, et al (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 60:1050-1058
55. Wagner TMU, Moslinger R, Zielinski C, Scheiner O, Brieteneder H (1996) New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families. Lancet 347:1263
56. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792